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A B S T R A C T
In this study, the antityrosinase and antioxidant activities of four guanidine compounds (GCs), including gua-
nylthiourea (GT), guanidine thiocyanate (GTC), phenylguanidine (PG), and phenethyldiguanide (PTDG), were
investigated. The results showed that the GCs reduced the monophenolase and diphenolase activities of tyr-
osinase. The IC50 values of GT, GTC, PG, and PTDG were 0.27, 3.53, 6.68, and 5.18mM for monophenolase and
0.23, 3.24, 3.97 and 2.50mM for diphenolase, respectively. The inhibition of diphenolase activity was reversible
for the four GCs. The inhibition types of GT and PTDG were competitive, while those of GTC and PG were mixed.
FRAP, ABTS, DPPH, and DNA damage protection assays revealed that only GT possessed significant antioxidant
activity. Furthermore, GT was found to decrease the melanin content and expression of TYR, MITF and DCT in
both B16F10 cells and zebrafish. Overall, our results indicated that GT can inhibit tyrosinase activity in vitro,
which suggests that these GCs are potential candidates for novel small-molecule tyrosinase inhibitors and that
GT could have broader application prospects.
1. Introduction
Tyrosinase (EC 1.14.18.1), a binuclear copper metalloenzyme oxi-
dase, is typically found in a variety of organisms [1]. Tyrosinase, the
key enzyme in melanin biosynthesis, converts L-Tyr hydroxylation to
3,4-dihydroxyphenylalanine (L-DOPA) and oxidizes L-DOPA to dopa-
quinone upon further reactions, ultimately causing melanin [2]. In re-
sponse to UV light, organisms produce more melanin pigment, which
darkens the skin, and abnormal accumulations of skin pigmentation
may cause serious pigmentation disorders. Taken together, research
regarding the regulation of melanin generation by the inhibition of
tyrosinase has become increasingly interesting [3]. In clinical applica-
tions, tyrosinase inhibitors could be used for the dermatological treat-
ment of pigmentation deposition. Tyrosinase inhibitors are equally
important commercially [4], as they play an important role in
whitening cosmetic products. In most fruits and vegetables, tyrosinase
inhibitors can inhibit the enzymatic browning induced by tyrosinase
and further extend the shelf life. In addition, tyrosinase plays key roles
in the growth and development of insects, as it functions in wound
healing, the defensive encapsulation and melanisation of foreign or-
ganisms, and cuticle sclerotisation. The development of insects can be
affected by regulation of their tyrosinase activity [5]. Although many
synthetic and natural tyrosinase inhibitors have been extensively
documented and reported, drug safety assessments have restricted their
applications in clinical trials and clinical practices [6,7]. Therefore, it is
necessary to find some other compounds that can be applied in other
fields and mass-produced. Exploring the potential inhibit tyrosinase
activity of these compounds and providing a theoretical basis for the
practical application of tyrosinase inhibitors are extremely essential.
Tyrosinase can catalyze the synthesis of melanin, thus it is practical
and feasible to regulate the generation and accumulation of melanin by
inhibiting tyrosinase. Melanogenesis involves numerous regulatory
pathways that can upregulate the expression of microphthalmia-asso-
ciated transcription factor (MITF). In addition, MITF can regulate
melanin-related gene expression. Tyrosinase (TYR) is a rate-limiting
enzyme that plays a catalytic role in the initiation of melanin synthesis.
Dopachrome tautomerase (DCT), which mediates the final few steps of
melanin synthesis, can catalyse the dopachrome to form unstable qui-
nones, and melanin is formed by further oxidation and polymerization.
Expression of the melanogenic enzymes TYR and DCT is regulated by
the helix-loop-helix transcription factor MITF [8]. In addition, TYR and
DCT are transcriptional targets of MITF. Melanocyte-stimulating
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hormone (a-MSH) plays a role in promoting the synthesis of TYR, sti-
mulates melanocytes and enhances melanogenesis [9]. In this study, we
explored the expression of MITF, TYR, DCT and a-MSH in cells and
zebrafish that are treated with guanidine compounds (GCs), which can
be used as the basis for studying the antimelanogenesis of GCs. The
guanidine structural motif is typically found in natural products and
bioactive compounds [10–12]. Compounds containing guanidine
groups are known to have a broad-spectrum antibacterial function, and
they have long been considered medicines and fungicides [13]. Due to
its unique role as a hydrogen bond donor to ionic energetic materials
and positive charge thermodynamic stability, the guanidine group is an
important pharmacophoric group and is often used in synthetic ligands
[14]. In addition, guanidine-containing compounds are good additives
for polymeric materials [13]. Moreover, guanidine and its derivatives
play important roles in various biological events in humans, such as
organocatalysis [15], channelling [16] and transport across corre-
sponding membranes and cells [17–20]. Because of their potent biolo-
gical activities, guanidine derivatives remain an important area of drug
development research [21,22]. Previous studies have demonstrated that
antidiabetic metformin has an inhibitory effect on melanogenesis [23];
however, no studies on tyrosinase inhibition kinetics in vitro have
previously been reported, and there are no other studies on tyrosinase
inhibitory activity with guanylthiourea (GT), guanidine thiocyanate
(GTC), phenylguanidine (PG), and phenethyldiguanide (PTDG). As a
result, the goal of this study was to analyse the inhibition of mushroom
tyrosinase activity with four GCs. In addition, their antioxidant activ-
ities and antimelanogenesis were further evaluated.
2. Materials and methods
2.1. Materials
Mushroom tyrosinase (EC 1.14.18.1), L-DOPA, L-Tyr, DPPH, ABTS,
and ascorbic acid were all purchased from Sigma-Aldrich (St. Louis,
MO, USA). DMEM, penicillin, streptomycin, FBS and trypsin-EDTA
were purchased from Gibco. GT and PTDG were obtained from Aladdin
(Shanghai, China). GTC and 1-anilino-8-naphthalene sulfonate (ANS)
were obtained from Sangon Biotech (Shanghai, China). PG was ob-
tained from Yuanye Biotech (Shanghai, China), respectively. The pu-
rities of GT, GTC, PG and PTDG were up to 98%, 99%, 98% and 97%,
respectively. Other reagents were of standard analytical grade. The
water used in this research was double-distilled.
2.2. Antityrosinase assay
The assay for mushroom tyrosinase was performed spectro-
photometrically as described previously with slight modifications [24].
L-Tyr was used as a substrate of the monophenolase of mushroom
tyrosinase, and L-DOPA was used as a substrate of the diphenolase of
mushroom tyrosinase. The assay conditions included a 3mL reaction
system containing distilled water, 1.0mM L-Tyr or 0.5 mM L-DOPA,
50mM Na2HPO4-NaH2PO4 buffer (pH 6.8) and different concentrations
of effectors. The final effective concentrations of mushroom tyrosinase
were 6.66 and 3.33×10−3 g L-1 for the monophenolase and diphe-
nolase reaction systems, respectively [25]. The inhibitory types and
constants were detected principally with reference to previously re-
ported methods [26]. Using the Line-weaver Burk plot, the inhibition
types were determined, and the inhibition constants were obtained by
secondary plots of the apparent 1/Vm or Km/Vm versus the concentra-
tions of the inhibitors [27].
2.3. Scanning study
The assay was performed according to the kinetic analysis method
provided by Jimenez-Atienzar et al. [28] with some modifications. L-
Tyr (1mM) and L-DOPA (0.5mM) were oxidized by tyrosinase in the
reaction system (50mM Na2HPO4-NaH2PO4 buffer, pH 6.8) with and
without the inhibitors. Spectra at wavelengths of 240–700 nm from 0 to
8 or 10 to 18min were recorded with the Thermo Scientific Multiskan
Go instrument.
2.4. Fluorescence quenching analysis
With an excitation wavelength of 290 nm and emission slit widths of
5 nm, the fluorescence intensities of tyrosinase in the presence of ef-
fectors were trailed and recorded using a Varian Cary Eclipse fluores-
cence spectrophotometer. Different concentrations of GCs were added
to a 2×10−3 L 0.2 g L-1 tyrosinase solution, and changes in fluores-
cence intensity were detected. The final mixture was preincubated at
25 °C for 1min. In addition, ANS-binding fluorescence quenching ana-
lysis was performed using a Varian Cary Eclipse fluorescence spectro-
photometer. The mixture of tyrosinase and 0.3 mM ANS was incubated
for 5min prior to the addition of GCs at 1×10-4 L. The fluorescence
quenching is described by the Stern-Volmer equation [29] as follows:
F0/F= 1 + Kqτ0[I]= 1 + KSV[I]
Wherein F0 and F are the fluorescence intensities before and after the
addition of GCs, respectively, Kq is the bimolecular quenching constant,
τ0 (10–8 s) is the lifetime of the fluorophore in the absence of GCs, [I] is
the concentration of GCs, and KSV is the Stern–Volmer quenching
constant.
2.5. Native-PAGE electrophoresis
Native-PAGE was implemented to study the interaction between
tyrosinase and inhibitors according to the method designed by Rui Xing
et al. [30] with slight modifications. Tyrosinase was dissolved in
Na2HPO4-NaH2PO4 buffer (50mM, pH 6.8), and the final activity in the
sample was 1 U L−1. After electrophoresis, the gels were excised and
divided into three parts: marker and two parts of tyrosinase. Marker
and a part of tyrosinase were stained with coomassie brilliant blue, the
rest of tyrosinase were dropped into the different concentrations in-
hibitors and then incubated in 15mM L-DOPA at 37 °C for vital
staining. All steps were performed at 4 °C except for vital staining.
2.6. Molecular docking simulation
To explore the mechanism of action of GCs on mushroom tyr-
osinase, molecular operation environment (MOE) 2008 software was
used. The tyrosinase structure of Agaricus bisporus was obtained from
the Protein Data Bank (ID: 2Y9W) and the 3D structure of GCs were
drawn using Chembiodraw Ultra 14.0. The energy of the structure was
minimized, and hydrogens were added using the protonate 3D module
of the MOE programme. Parameters for docking were partially
amended according to the method of Cui et al. [31].
2.7. Antioxidant activity analysis and DNA damage protection assay
GCs were evaluated for their ability to scavenge the DPPH radical
according to the method presented in an earlier study with appropriate
modifications [32,33]. The mixture of effectors and DPPH solution was
incubated for 30min at 25 °C in the dark. The absorbance of the mix-
ture (Ai) was detected immediately at 517 nm. The initial and blank
samples were measured without GCs (A0) and DPPH (Aj), respectively.
The abilities of four GCs to scavenge DPPH radicals were analysed and
compared using the following formula:
Scavenging rate (%) = (A0-Ai+Aj) /A0× 100%
The ABTS assay was performed according to the method established
by Chai et al. [33] ABTS (7mM) and potassium persulfate (2.45mM)
were stoichiometrically mixed at a ratio of 1:1. The ABTS+ working
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solution was prepared by adding 80% ethanol to the mixture to obtain
an absorbance of 0.700 ± 0.050 at 734 nm. The reaction system
comprising the ABTS+ working solution and effectors were prepared
and stored at 37 °C for 6min; the equation used was the same as that
used in the DPPH assay. The FRAP assay was carried out according to
the method established by Arya et al. [34]. To freshly prepare the FRAP
reagent, Na2HPO4-NaH2PO4 buffer (0.2mM, 0.5 mL, pH 6.6), po-
tassium ferricyanide (10 g L−1) and different concentrations of the GC
solution were mixed and incubated (50 °C) for 20min, and tri-
chloroacetic acid, double-distilled water, and ferric trichloride were
added before the reaction was monitored. The reaction system was
preincubated for 10min, and the absorbance was read at 700 nm. In
this work, the system’s effectors and solution were mixed at a ratio of
1:5. The equation used to determine the reducing power ability was
similar to that used in the DPPH radical scavenging assay except the
locations of A0 and Ai were switched.
A DNA damage protection assay was performed according to pre-
viously established methods with some amendments [35]. The
1.2×10−5 L reaction system contained 3×10-6 L of pET-28a DNA,
3× 10-6 L of 1mM FeSO4, 2× 10-6 L of effector solution, and 4×10-6
L of H2O2 (15%); the reagents were added to the reaction system and
incubated at 37 °C for 1 h. The mixtures were electrophoresed on a 1%
agarose gel.
2.8. Effect of GCs on the proliferation of cells (LO2, B16F10)
The effect of GCs on cell proliferation was evaluated by the MTT
assay [36]. Log-phase cells under good growth conditions were selected
and digested with 0.25% trypsin. The cell suspension was prepared with
fresh DMEM containing 10% foetal bovine serum and adjusted to a
density of 7× 103 cells/mL. Then, 200 μL of the cell solution was pi-
petted into a 96-well plate and cultured in an incubator (37 °C, 5%
CO2). After 12 h of incubation, the cells were attached, and the old
medium was replaced with different concentrations of the effector
(dissolved in DMEM). After the cells were cultured for 24 h, 48 h, and
72 h, 20 μL of the 5mg/mL MTT working solution was added, and the
mixture was incubated for 4 h. Next, 150 μL of DMSO was added to each
well, and the mixture was incubated for 15min under normal tem-
perature and vibration conditions. The absorbance of each well was
measured at 570 nm, and the cell viability (%) was calculated according
to the following formula:
Cell viability (%)= (Asample-Ablank)/(Acontrol-Ablank)×100%.
2.9. Tyrosinase activity in mouse B16F10 cells
The tyrosinase activity in B16F10 cells was determined by mea-
suring the oxidation rate of L-DOPA [37]. Cells were inoculated into 6-
well plates at 3× 105 cells per well and treated with GCs after 12 h of
culturing. After 72 h, the cell suspension was collected and resuspended
in PBS three times. Then, 150 μL of 1% Triton X-100 was added to each
sample, which was then frozen and thawed three times prior to being
centrifuged at 12,000 r min−1 for 20min. The supernatant was col-
lected as a crude tyrosinase extract. The Bradford method was used to
determine the protein content in the solution [38]. The reaction system,
which contained 20 μL of the supernatant and 180 μL of 0.5 mM L-
DOPA, was incubated in a 96-well plate at 37 °C for 30min, and the
absorbance at 475 nm was measured.
2.10. Melanin content in mouse B16F10 cells
The content of melanin in the cells was measured according to the
NaOH lysis method, and the cell sediment was collected as described for
the above experiment [39]. Cell precipitation samples were collected
after centrifugation, 150 μL of 1mM NaOH solution (containing 10%
DMSO) was added to each sample, mixed thoroughly and lysed at 80 °C
for 1 h. After that, the precipitate was removed by centrifugation, and
the supernatant was analyzed for melanin content. The absorbance of
supernatant was measured at a wavelength of 475 nm in a 96-well
plate.
2.11. Zebrafish embryo exposure experiment
Zebrafish (Danio rerio) farming was carried out according to a pre-
vious report [40]. Different concentrations of effector solutions were
dissolved in zebrafish embryo culture Holfretor water (0.05 g/L KCl,
0.1 g/L CaCl2, 0.025 g/L NaHCO3, 3.5 g/L NaCl). To explore the op-
timal concentration of GCs in zebrafish embryos, the following ex-
periment was carried out. In brief, 3 mL of Holfretor water and 40
embryos were placed in each well of a 6-well plate. After 2 h, the
Holfretor water was removed, and 3mL of each GC solution at different
concentrations was added. Then, growth properties of the embryos,
including morphological development, death, number of hatching em-
bryos and abnormal growth, were observed at 12 h intervals. The dead
embryos were removed from the well, and the solution was changed
every 12 h. Untreated embryos were used as a control. After de-
termining the optimal concentration of the effectors on the zebrafish
embryos, the exposure experiment was carried out. The melanin pro-
duced by the embryos was observed under a Leica M165 FC Stereo
Microscope at 48 h and 72 h after drug treatment, and photos were
acquired.
2.12. Western blot assay
B16F10 cells and zebrafish were collected, washed with prechilled
PBS, and lysed with ice-cold RIPA buffer. Protein concentrations were
determined using the Bradford method. The protein solution was he-
ated at 95 °C for 10min after treatment with loading buffer. After
electrophoresis (10–15% SDS-PAGE), the protein was transferred to a
PVDF membrane and blocked with 5% BSA for 1 h. The membrane was
incubated with primary antibodies at 4 °C for 12 h and with secondary
antibodies for 1 h. After the solution was changed, the membrane was
washed with TBST three times for 5min. The blots were detected with
the ECL system (Pierce Co.).
3. Results
3.1. Inhibitory effects of GCs on mushroom tyrosinase activity
The structures of GT, GTC, PG and PTDG are shown in Fig. 1A. We
detected the effects of four GCs on the oxidation of L-Tyr and L-DOPA
catalysed by mushroom tyrosinase. For the monophenolase of mush-
room tyrosinase, the reaction system maintained a steady rate after the
lag time (characteristic of monophenolase activity), and the product
curve increased in a linear fashion with increasing reaction time and
progressed to the end. The slope of the line represents the steady-state
rate. The lag time (Fig. 1B–I) and steady-state rates with different
concentrations of GCs (Fig. 1B–II) were analysed and are summarized in
Table 1. The change in lag time and decrease in steady-state rates with
increasing effector concentrations were obvious. The lag time increased
to 200%, 200%, 126%, and 123% for GT, GTC, PG and PTDG, respec-
tively, and the concentrations of effectors increased to 0.667, 6.667,
8.333 and 6.667mM, respectively. The IC50 values of GT, GTC, PG and
PTDG were 0.27, 3.53, 6.68 and 5.18mM, respectively, as shown in
Table 1.
For the diphenolase of mushroom tyrosinase, the formation of the
product during the oxidization reaction of L-DOPA by mushroom tyr-
osinase was synchronized with the reaction time, and the activity of
tyrosinase decreased with increasing concentrations of the GCs, which
was dose-dependent (Fig. 2A). The IC50 values for GT, GTC, PG and
PTDG were 0.23, 3.04, 3.97 and 2.50mM, respectively (Table 1). The
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Fig. 1. Effects of the guanidine compounds (GCs) on monophenolase of mushroom tyrosinase. A: Chemical structures of guanylthiourea (GT), guanidine thiocyanate
(GTC), phenylguanidine (PG), and phenethyldiguanide (PTDG). Inhibitory effects of the GCs on monophenolase (B) activity of mushroom tyrosinase. Effects on the
lag time of monophenolase (B–I). Effects on the stable activity of L-Tyr by the enzyme (B-II). a, b, c and d represent GT, GTC, PG and PTDG, respectively.
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relationship between the remaining enzyme activity and enzyme con-
centrations at different concentrations of GCs is shown in Fig. 2B. If the
inhibitor’s action on diphenolase is reversible, the results are demon-
strated as a family of straight lines that all pass through the origin [41].
If it is irreversible, the results are presented as a family of parallel lines
[42]. The results indicated that all GCs were reversible inhibitors of
mushroom tyrosinase. An increase in the concentrations of GCs reduced
the slopes of the lines, which indicated that the GCs reduced the en-
zyme activity but did not change the amount of active enzyme.
3.2. Inhibition types and constants of GCs on diphenolase activity
For GT and PTDG, the plots of 1/v versus 1/[S] presented as a fa-
mily of lines with different slopes and intersected at the Y-axis
(Fig. 2C–aI, C–dI), indicating that the Michaelis-Menten constant (Km)
values increased with increasing inhibitor concentration. The Vm value
remained unchanged, and both GT and PTDG were competitive in-
hibitors. For GTC and PG, the plots of 1/v versus 1/[S] presented as a
family of lines with different slopes (Fig. 2C–bI, C–cI) and intercepts
(Fig. 2C–bII, C–cII) and intersected in the second quadrant, indicating
that GTC and PG were mixed-type inhibitors. The inhibition constant
(KI) and enzyme-substrate complex (KIS) values, shown in Table 1, were
obtained from the plots of the slopes versus the concentrations of the
inhibitors and the vertical intercepts versus the concentrations of the
inhibitors.
3.3. The inhibitory effects of GCs on the oxidation process of L-DOPA and
L-Tyr
The full-wave scanning method was performed during the enzy-
matic oxidation of L-DOPA and L-TYR in the absence and presence
(Supporting Fig. 1B–E) of GT, GTC, PC and PTDG. The peaks at 303 and
475 nm indicated the formation of dopachrome (λmax= 302, 473 nm)
[43]. In the absence of GCs, the absorbance of the monophenolase
system at 475 nm was 0.59 at 10min, while that of the diphenolase
system at 475 nm was 0.59 in the initial phase of the reaction. When the
substrate was L-DOPA, after 10min, the existence of GT, GTC, PC and
PTDG exhibited peak intensities reduced by 41.72%, 31.74%, 52.75%
and 37.95%, respectively (Supporting Fig. 1B–I, C–I, D-I and E–I). As
shown in Supporting Fig. 1B–II, C–II, 1D-II and E-II, the inhibition rates
of the oxidation of L-Tyr were 11.05%, 16.06%, 18.09% and 11.18% by
GT, GTC, PC and PTDG, respectively.
3.4. The effects of GCs on intrinsic and ANS-binding fluorescence quenching
Proteins have intrinsic fluorescence properties because of the tryp-
tophan, tyrosine, and phenylalanine fluorophores. The inhibitors can
decrease the fluorescence intensities by approaching the surface or
active centre of the enzyme. Fluorescence quenching analysis has been
widely employed to explore the interaction between tyrosinase and
inhibitors. Fig. 3A shows that the increasing concentration of GT led to
a significant decrease in the intrinsic tyrosinase fluorescence spectra.
GT influenced the maximum fluorescence intensity but barely changed
the λem shift. When the concentration reached 0.198mM, the relative
fluorescence intensity was reduced to 39.59%. The results indicated
that GT might interact with tyrosinase and quench its intrinsic fluor-
escence. Stern-Volmer plot analysis was used to calculate the Stern-
Volmer quenching constants, shown in Table 2. The Ksv value reflects
the type of fluorescence quenching mechanism, and the Ksv of static
quenching is larger than 100 M−1 [44]. According to the Ksv, the type
of fluorescence-quenching mechanism for GT was static. We also stu-
died the effects of GTC, PG and PTDG on the fluorescence quenching of
tyrosinase. PG exerted the same effect as GT (Fig. 3B). However, GTC
and PTDG did not work with intrinsic fluorophores of tyrosinase. The
Scatchard equation can be applied to describe static quenching as fol-
lows:
Lg [(F0 - F)/F] = lgKa + nlg[I].
wherein Ka is the apparent binding constant, n is the binding affinity.
To explore hydrophobic surface changes in tyrosinase, we carried
out an ANS-binding fluorescence quenching experiment. As shown in
Fig. 3C, D, GCs exhibited the maximum ANS fluorescence intensity
increase, indicating that GCs interact with tyrosinase and induce hy-
drophobic surfaces, resulting in tyrosinase exposure.
3.5. Inhibitory effects of GCs on tyrosinase as determined by Native-PAGE
electrophoresis
The molecular weights of tyrosinase are 30–34, 42–46 and
64–68 kDa according to previous reports [30]. As shown in Fig. 4A-Lane
2, the gel showed in depicts was tyrosinase with molecular weights of
42–46 kDa and 64–68 kDa. The tyrosinase gels shown in Fig. 4A-Lanes
3–22 were soaked in the inhibitors prior to the L-DOPA staining. For
GCs, as the concentration increased, the colour of the activity staining
bands became increasingly shallow. Furthermore, the 42–46 kDa band
was the first to disappear. GT effectively inhibited tyrosinase activity,
even at low concentrations (Fig. 4A-Lanes 3–7). The activity of
42–46 kDa tyrosinase was inhibited at low concentration of GCs, while
64–68 kDa tyrosinase was less affected. As the concentration increased,
64–68 kDa tyrosinase was inhibited. The same results were obtained
when the samples were treated with GTC (Fig. 4A-Lanes 8–12), PG
(Fig. 4A-Lanes 13–17) and PTDG (Fig. 4A-Lanes 18–22) at higher
concentrations.
3.6. Molecular docking
The docking mode of GCs in the catalytic active centre was ex-
amined to elucidate the inhibitory mechanism. In Fig. 4B, GT and PG
displayed a metal contact with Cu (purple dotted line). The green arrow
was shown as the sidechain receptor or donor in molecular docking
models. As shown in the results, hydrogen bonds was formed by free
hydrogen of amino and the residues His263, His259 and Glu256 were
in the centre of the active site. It was observed that GT was accom-
modated in a spacious cavity formed by His61, His85, Asn260, Phe292,
His259, Glu256, His263, Phe264, Ala286. For PG, Asn260 interacted
with free hydrogen of amino and nitrogen of sulfur cyano to form hy-
drogen bonds, His259 interacted with the nitrogen of imino group to
Table 1
Effects of GCs on the activity of mushroom tyrosinase.
Compd. IC50 (mM) Inhibition Inhibition constants (mM)
monophenolase diphenolase mechanism type KI KIS
GT 0.27 0.23 reversible competitive 0.18
GTC 3.53 3.04 reversible mixed 1.78 4.88
PG 6.68 3.97 reversible mixed 3.74 29.05
PTDG 5.18 2.50 reversible competitive 1.22
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Fig. 2. Effects of the GCs on diphenolase of mushroom tyrosinase. Inhibitory effects of the GCs on diphenolase (A) activity of mushroom tyrosinase. Determination of
the inhibition mechanisms of GCs on mushroom tyrosinase (B). Determination of the inhibition type and constants of GCs on tyrosinase (C). a, b, c and d represent
GT, GTC, PG and PTDG, respectively. The concentrations of GT for curves 1–5 were 0, 0.17, 0.33, 0.50 and 0.67mM, respectively. The concentrations of GTC and
PTDG for curves 1–5 were 0, 1.67, 3.33, 5.00, and 6.67mM, respectively. The concentrations of PG for curves 1–5 were 0, 2.08, 4.17, 6.25, and 8.33mM, re-
spectively.
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form hydrogen bonds. There were seven residues around PG that
formed the spacious cavity in the centre of the active site but did not
interact with PG (Fig. 4B). Similarly hydrogen bonds were observed in
PG and PTDG molecular docking models. In addition, the four GCs had
hydrophobic amino acid residues near the docking position of tyr-
osinase, such as Phe292, Ala286, Val283. These interactions are im-
portant factors underlying how GCs inhibit enzyme activity.
3.7. Effects of GCs on DNA damage protection and antioxidant potential
The antioxidant activities of GCs were evaluated using DPPH, ABTS
and FRAP assays. Fig. 5A and B show the DPPH and ABTS radical
scavenging activities of GCs at different concentrations, respectively.
Fig. 5C shows the FRAP results, which were used to assess the anti-
oxidant activities. Only GT had relatively high effects with EC50 values
of 0.133/0.054 and 0.041mM in the DPPH/ABTS and FRAP assays,
respectively. The results also showed that GT eliminated DPPH and
ABTS radicals in a concentration-dependent manner, and the same
dose-dependent activity was observed in the FRAP assay. However,
increasing concentrations did not contribute to stronger effects on an-
tioxidant activity for GTC, PG or PTDG. Moreover, GTC exerted more
effective activity than PG and PTDG.
The protective effects of GCs on oxidative DNA strand breakage
were evaluated using pET-28a plasmid DNA. The super-labelled
Fig. 3. The effects of GCs on fluorescence quenching. Changes in intrinsic tyrosinase fluorescence at different concentrations of GT (A) and PG (B); the concentrations
of GT and PG for curves 1–11 ranged from 0 to 0.2 and 2.5mM, respectively [I]. Relative intensity of tyrosinase at different concentrations of effectors (II); Stern-
Volmer plot describing the tyrosinase quenching caused by association with quencher (III); Plot of log[(F0-F)/F] against log[I] for tyrosinase and various con-
centrations of quencher (IV). F0 and F are the fluorescence intensities before and after the addition of the quencher, respectively. ANS-binding fluorescence spectra of
tyrosinase with different concentrations of GCs (C). Relative ANS fluorescence intensity of tyrosinase in the presence of increasing concentrations of GCs (D). (I), (II),
(III) and (IV) represent GT, GTC, PG and PTDG, respectively. The concentrations of GT, GTC, PG and PTDG for curves 1–7 ranged from 0 to 2, 9.09, 11.90 and
9.62mM, respectively. Curve 8 shows 0.3mM ANS.
Table 2
Fluorescence parameters for the interaction between quenchers and tyrosinase.
Compd. Type of
quenching
KSV (M−1) Ka (M−1) Kq (M−1 s−1) n
GT Static 8.028×103 1.592× 104 8.028× 1011 1.425
PG Static 4.604×102 4.018× 102 4.604× 1010 1.232
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plasmid (pET-28a) was treated with specific oxidizers (FeSO4 and
H2O2) to induce DNA breakage. For the assessment of DNA protection,
shown in Fig. 5D, plasmid DNA chain scission was obviously treated
with FeSO4 and H2O2. The four GCs were used at varying concentra-
tions to assess the protection abilities on oxidative DNA strand
breakage. GT had a good DNA protection ability (Fig. 5D-Lanes 3–6).
GTC at concentrations of 16 and 32mM showed protective effects, but
little DNA protection was observed at 4 and 8mM (Fig. 5D- Lanes
7–10). PG and PTDG showed little protection at lower concentrations
and partial DNA protection at 32mM (Fig. 5D-Lanes 11–14 and 5D-
Lanes 15–18).
3.8. Effects of GCs on the proliferation of cells (LO2, B16F10)
The proliferation rate of cells was determined by the MTT assay, and
the effects of GCs on cell proliferation in vitro were analysed. Fig. 6A
shows the effects of GC on LO2 cell proliferation. The viability rate of
LO2 cells fluctuated by approximately 100% within the selected con-
centration and time range. The small effect on cell proliferation in the
range of the experimental drug concentrations indicates that the com-
pound does not harm humans. Fig. 6B shows the proliferative effect of
GCs on B16F10 cells in vitro. As the results show, GCs had little effect
on cell proliferation after 24 h of treatment. However, as time in-
creased, the proliferation rate of cells showed a certain inhibitory effect.
When the concentration reached 5mM, the inhibition rate reached
50%.
3.9. Effect of GT on tyrosinase activity and melanin contents in mouse
B16F10 cells
According to the above experimental results, a GT with a better
effect was selected as an effector for subsequent research. The
Fig. 4. Analysis of the inhibitory mechanism by Native-PAGE and molecular docking.
Electrophoretic analysis of the inhibitory effects of GCs on the diphenolase activity of mushroom tyrosinase (A). Lanes 1-2: protein molecular weight marker and
tyrosinase stained with L-DOPA; Native-PAGE analysis of the inhibitory effects of GCs on mushroom tyrosinase (Lanes 3–22). Lanes 3-7: the concentrations of GT
were 0, 0.1, 0.2, 0.4 and 0.8mM, respectively. Lanes 8–12, 13–17 and 18-22: the concentrations of GTC, PG and PTDG were 0, 1, 2, 4 and 8mM, respectively.
Molecular docking simulation of four GCs with tyrosinase (B).
Y.-X. Wang, et al. Process Biochemistry 85 (2019) 84–96
91
inhibitory effect of GT on cell melanin production is shown in Fig. 7A.
The cellular melanin contents were significantly decreased at con-
centrations of 0.4 mM. Fig. 7B shows that the tyrosinase derived from
B16F10 cells was inhibited by GT, and the inhibitory effect was dose-
dependent, which was consistent with the results of the mushroom
tyrosinase.
3.10. Effect of GT on melanin content in zebrafish embryos
The results of zebrafish embryos treated with GT are shown in
Fig. 8B. Compared with that in the control group, the total melanin
content decreased with increasing GT concentration. In the blank
control group, numerous black spots were clearly observed on the
upper and lower sides of the zebrafish. However, in the group receiving
GT treatment, the melanin content was decreased in both the spine and
back of the zebrafish. When the concentration of GT was 16mM, the
melanin content was significantly reduced, and there was no obvious
melanin deposition point. Fig. 8A, C shows the results of the extraction
of melanin, revealing that melanin production was remarkably sup-
pressed compared with that in the control group.
3.11. Effect of GT on tyrosinase-related protein expression
GT had a significant inhibitory effect on tyrosinase activity in
B16F10 cells, and we further investigated the effect of GT on the ex-
pression of tyrosinase-related proteins, B16F10 cells and zebrafish
embryos treated with different concentrations of GT. Samples were
collected and prepared protein for Western blot analysis, and the effects
of GT on the expression of tyrosinase-related proteins were in-
vestigated. As shown in Fig. 9, after GT treatment, the expression levels
of the TYR, MITF and DCT proteins were significantly downregulated in
B16F10 cells (Fig. 9A) and zebrafish embryos (Fig. 9B) in a dose-de-
pendent manner, while the expression levels of α-MSH were not af-
fected.
4. Discussion
In this study, we evaluated the inhibitory activities of four GCs
against mushroom tyrosinase for the first time. The antityrosinase ac-
tivity assays showed that four GCs had inhibitory effects on mono-
phenolase and diphenolase activity. For the monophenolase activity,
the four GCs affected both the lag time and steady-state activity. For the
diphenolase activity, the four GCs were reversible inhibitors, which
indicated that the effectors could decrease the activity of tyrosinase
without requiring a concomitant change in the amount of efficient
enzyme. Furthermore, the four GCs presented two different inhibitory
capacities. GT and PTDG inhibited the free enzyme by binding the ac-
tive site of tyrosinase, while GTC and PG inhibited both the free enzyme
and the enzyme-substrate complex. GT had a better inhibitory effect
than PTDG and GTC, while PG was the weakest. The results were
confirmed by spectroscopy and Native-PAGE electrophoresis. However,
while GT and GTC are a pair of isomers, they had different effects,
which implies that thiourea is an important determinant of tyrosinase
inhibition by GT.
To explore the potential molecular mechanism of GC inhibition on
tyrosinase, molecular docking and fluorescence quenching studies were
performed. As shown in Table 2, the Kq values of GT and PG were
substantially greater than the maximum scattering collisional
quenching constant (2.0× 10−10 M-1 s-1) in water, which implied that
the interaction of the two GCs and tyrosinase is static and that they can
form a complex with no fluorescence. Interestingly, no significant λem
shift was observed in the intrinsic tyrosinase fluorescence spectra after
the addition of GCs. Therefore, the interaction between tyrosinase and
these two GCs had no direct influence on the quenched residues of
tyrosinase, which might be related to hydrophobic effects because hy-
drophobic amino acid groups, such as Phe-264 and Phe-90, exist around
the docking sites. For GTC and PTDG, no decrease in intrinsic tyrosinase
fluorescence intensity was observed within the scope of the setting
concentration, perhaps because GTC and PTDG did not interact with the
intrinsic fluorophores of tyrosinase. However, the four GCs altered the
Fig. 5. Antioxidant activity of GCs. Evaluation of the antioxidant activities of GCs using the DPPH (A), ABTS (B), and FRAP (C) methods. Each value is expressed as
the mean ± S.D. (n=3). Inhibitory effects of GCs on plasmid DNA degradation caused by hydroxyl radicals (D). M: 1 kb ladder. Lane 1: control supercoiled pET-28a
plasmid DNA; Lane 2: pET-28a plasmid DNA, 1% FeSO4 and 15% H2O2; Lanes 3-6: effects of 0.5, 1, 2, 4mM GT on 1% FeSO4 and 15% H2O2 induced pET-28a plasmid
DNA strand breakage. Lanes 7–10, 11–14, 15-18: effects of 4, 8, 16, 32mM GTC, PG and PTDG on 1% FeSO4 and 15% H2O2 induced pET-28a plasmid DNA strand
breakage, respectively.
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state of the hydrophobic regions of tyrosinase, and the ANS fluores-
cence intensities increased, probably due to the GC-induced exposure of
the fluorescence of the hydrophobic regions. Within a certain con-
centration change range, the relative maximum ANS fluorescence in-
tensity exhibited a dose-dependent relationship. Likewise, the mole-
cular docking results indicated no obvious interaction between the four
GCs and tryptophan, a residue often found among the intrinsic aromatic
fluorophores in tyrosinase molecules. As the results indicated, GT and
PG could combine with the copper ions located in the active site of the
enzyme, which could be a major reason underlying why GT and PG had
stronger effects on fluorescence quenching than the other two com-
pounds. The antioxidant results were similar to the antityrosinase ef-
fects. GT exhibited stronger DPPH/ABTS scavenging activities and an-
tioxidant activities, while PTDG, PG and GTC had less activity. At the
molecular level, the four GCs were able to prevent plasmid DNA da-
mage induced by oxidizing agents. Four GCs had different effects on the
oxidative damage protection of DNA, among which GT has the stron-
gest effect. Therefore, we speculated that thiourea groups were
important for compounds to exhibit better antioxidant activity and DNA
damage protection, and strong antioxidant active drugs had more
protective effects on DNA damage protection.
Based on the inhibitory mechanism of GCs on mushroom tyrosinase,
we further demonstrated the melanogenesis regulatory effect of GT on
B16F10 cells and zebrafish, and suppression of melanogenesis was ob-
served (Figs. 7 and 8). We speculated that GT regulated melanogenesis
by maintaining MITF at a low expression level and further down-
regulating the expression of TYR and DCT. However, no significant
difference in the expression of a-MSH was observed (Fig. 9). In con-
clusion, our study suggests that GT exerts significant antimelanogenic
activity by downregulating the expression of MITF, TYR and DCT rather
than by directly inhibiting tyrosinase activity. In the study of animal
models, the drug's cell membrane permeability is also a factor affecting
its function. For example, the IC50 value of GT on mushroom tyrosinase
activity was only 0.23mM, while the study of GT on melanogenesis in
zebrafish and melanoma cells yielded a substantially higher IC50 value.
This result may have been due to differences in tyrosinase among
Fig. 6. Effects of GCs on LO2 (A) and B16F10 (B) cell proliferation in vitro. (I), (II), (III) and (IV) represent GT, GTC, PG and PTDG, respectively.
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species or to the low cell membrane permeability of GT.
Taken together, our results revealed that four GCs had inhibitory
effects on tyrosinase, and their strategies of inhibition were different.
The results also showed the differing effects of chemical isomers on the
activity of tyrosinase. Based on the molecular docking results obtained
using MOE, we hypothesized that thiourea-containing compounds may
have advantages over guanidine-containing compounds in interacting
with tyrosinase. Furthermore, the antioxidant activities of the four GCs
were consistent with the antityrosinase activity, and GT showed a re-
markable advantage, although the other three GCs also had partial
antioxidant effects. In addition, Lee et al. [45] reported that anti-
oxidants presented better free radical scavenging activity when the
EC50 was less than 10 g L−1. Therefore, for GTC, PG and PTDG, the
antioxidant activity and DNA damage protection validated the super-
iority of GT. We also detected the effect of GT on melanin synthesis, and
the results suggested that GT could effectively inhibit the generation of
melanin and spots by suppressing the expression of melanin synthesis-
related proteins. According to this study, the GT derivatives have been
found to have potential antimalarial and anticancer activities [46].
PTDG has been used in the treatment of type II diabetes mellitus [47].
GTC and PG are mainly used as chemical reagents in scientific research
[48,49]. The inhibitory effect of the four GCs on tyrosinase have not yet
been reported. Therefore, our study provides a new idea for the re-
search and development of GCs, as tyrosinase inhibitors and anti-
oxidants can be used in food preservation, cosmetic medicine, in-
secticides, bactericides, etc., and GT is a good tyrosinase inhibitor and
could have broader application prospects.Fig. 7. Inhibitory effects of GT on melanogenesis (A) and on tyrosinase activity
(B) in B16F10 melanoma cells.
Fig. 8. Inhibitory effects of GT on melanogenesis in zebrafish embryos. Melanin content in zebrafish embryos. (A, B); The inhibition ratio of melanin synthesis (C).
Y.-X. Wang, et al. Process Biochemistry 85 (2019) 84–96
94
Funding
This work was financially supported by the Natural Science
Foundation of China (No.31571896, 31570785 and 31870780) and the
National Science Foundation for Fostering Talents in Basic Research of
the National Natural Science Foundation of China (No. J1310027).
Appendix A. Supplementary data
Supplementary material related to this article can be found, in the
online version, at doi:https://doi.org/10.1016/j.procbio.2019.07.003.
References
[1] Q.X. Chen, K.K. Song, Q. Wang, H. Huang, Inhibitory effects on mushroom tyr-
osinase by some alkylbenzaldehydes, J. Enzyme Inhib. Med. Chem. 18 (2003)
491–496.
[2] M. Valko, D. Leibfritz, J. Moncol, M.T.D. Cronin, M. Mazur, J. Telser, Free radicals
and antioxidants in normal physiological functions and human disease, Int. J.
Biochem. Cell Biol. 39 (2007) 44–84.
[3] E.V. Curto, C. Kwong, H. Hermersdorfer, H. Glatt, C. Santis, V. Virador,
V.J. Hearing, T.P. Dooley, Inhibitors of mammalian melanocyte tyrosinase: in vitro
comparisons of alkyl esters of gentisic acid with other putative inhibitors, Biochem.
Pharmacol. 57 (1999) 663–672.
[4] M. Shiino, Y. Watanabe, K. Umezawa, Synthesis of N-substituted N-nitrosohy-
droxylamines as inhibitors of mushroom tyrosinase, Bioorg. Med. Chem. 9 (2001)
1233–1240.
[5] M. Ashida, P.T. Brey, Role of the integument in insect defense - pro-phenol oxidase
cascade in the cuticular matrix, Proc. Natl. Acad. Sci. U. S. A. 92 (1995)
10698–10702.
[6] Z.-C. Li, L.-H. Chen, X.-J. Yu, Y.-H. Hu, K.-K. Song, X.-W. Zhou, Q.-X. Chen,
Inhibition kinetics of chlorobenzaldehyde thiosemicarbazones on mushroom tyr-
osinase, J. Agric. Food Chem. 58 (2010) 12537–12540.
[7] W.-M. Chai, Y. Shi, H.-L. Feng, L. Xu, Z.-H. Xiang, Y.-S. Gao, Q.-X. Chen, Structure
characterization and anti-tyrosinase mechanism of polymeric proanthocyanidins
fractionated from kiwifruit pericarp, J. Agric. Food Chem. 62 (2014) 6382–6389.
[8] M.O. Villareal, S. Kume, M. Neffati, H. Isoda, Upregulation of Mitf by phenolic
compounds-rich cymbopogon schoenanthus treatment promotes melanogenesis in
B16 melanoma cells and human epidermal melanocytes, Biomed Res. Int. 13 (2017)
1–11.
[9] T. Yamauchi, K. Yamasaki, K. Tsuchiyama, S. Koike, S. Aiba, A quantitative analysis
of multilineage-differentiating stress-enduring (Muse) cells in human adipose tissue
and efficacy of melanocytes induction, J. Dermatol. Sci. 86 (2017) 198–205.
[10] R.G.S. Berlinck, A.E. Trindade-Silva, M.F.C. Santos, The chemistry and biology of
organic guanidine derivatives, Nat. Prod. Rep. 29 (2012) 1382–1406.
[11] R.G.S. Berlinck, A.C.B. Burtoloso, M.H. Kossuga, The chemistry and biology of or-
ganic guanidine derivatives, Nat. Prod. Rep. 25 (2008) 919–954.
[12] R.G.S. Berlinck, A.C.B. Burtoloso, A.E. Trindade-Silva, S. Romminger, R.P. Morais,
K. Bandeira, C.M. Mizuno, The chemistry and biology of organic guanidine deri-
vatives, Nat. Prod. Rep. 27 (2010) 1871–1907.
[13] M.N. Gorbunova, T.D. Batueva, Synthesis of guanidine-containing copolymers and
their applications in the sorption of transition metals, Polym. Adv. Technol. 28
(2017) 152–158.
[14] T.M. Klapotke, P. Mayer, C.M. Sabate, J.M. Welch, N. Wiegand, Simple, nitrogen-
rich, energetic salts of 5-nitrotetrazole, Inorg. Chem. 47 (2008) 6014–6027.
[15] M. Marchegiani, M. Nodari, F. Tansini, C. Massera, R. Mancuso, B. Gabriele,
M. Costa, N. Della Ca, Urea derivatives from carbon dioxide and amines by gua-
nidine catalysis: easy access to imidazolidin-2-ones under solvent-free conditions, J.
Co2 Util. 21 (2017) 553–561.
[16] R. Yang, Y.Q. Liu, C. Blanchard, Z.K. Zhou, Channel directed rutin nano-en-
capsulation in phytoferritin induced by guanidine hydrochloride, Food Chem. 240
(2018) 935–939.
[17] J.K. Chun, L. Zhang, M. PiquetteMiller, E. Lau, L.Q. Tong, K.M. Giacomini,
Characterization of guanidine transport in human renal brush border membranes,
Pharm. Res. 14 (1997) 936–941.
[18] E. Cova, U. Laforenza, G. Gastaldi, Y. Sambuy, S. Tritto, A. Faelli, U. Ventura,
Guanidine transport across the apical and basolateral membranes of human in-
testinal Caco-2 cells is mediated by two different mechanisms, J. Nutr. 132 (2002)
1995–2003.
[19] N. Kimura, S. Masuda, T. Katsura, K. Inui, Transport of guanidine compounds by
human organic cation transporters, hOCT1 and hOCT2, Biochem. Pharmacol. 77
(2009) 1429–1436.
[20] S. Zevin, M.E. Schaner, N.P. Illsley, K.M. Giacomini, Guanidine transport in a
Fig. 9. Western blot analysis of α-MSH, MITF, TYR, DCT and MITF in B16F10 cells (A) and zebrafish embryos (B) treated with GT.
Y.-X. Wang, et al. Process Biochemistry 85 (2019) 84–96
95
human choriocarcinoma cell line (JAR), Pharm. Res. 14 (1997) 401–405.
[21] J.V. Alegre-Requena, E. Marques-Lopez, R.P. Herrera, Guanidine motif in biologi-
cally active peptides, Aust. J. Chem. 67 (2014) 965–971.
[22] C.J. Zeng, C.J. Chen, C.W. Chang, H.T. Chen, T.C. Chien, Copper(I) iodide-catalyzed
synthesis of N,N’ ’-disubstituted guanidines from N-substituted cyanamides, Aust. J.
Chem. 67 (2014) 1134–1137.
[23] A. Lehraiki, P. Abbe, M. Cerezo, F. Rouaud, C. Regazzetti, B. Chignon-Sicard,
T. Passeron, C. Bertolotto, R. Ballotti, S. Rocchi, Inhibition of melanogenesis by the
antidiabetic metformin, J. Invest. Dermatol. 134 (2014) 2589–2597.
[24] I. Kubo, I. Kinst-Hori, Tyrosinase inhibitors from cumin, J. Agric. Food Chem. 46
(1998) 5338–5341.
[25] L.-H. Chen, Y.-H. Hu, W. Song, K.-K. Song, X. Liu, Y.-L. Jia, J.-X. Zhuang, Q.-
X. Chen, Synthesis and antityrosinase mechanism of benzaldehyde thiosemicarba-
zones: novel tyrosinase inhibitors, J. Agric. Food Chem. 60 (2012) 1542–1547.
[26] Y.H. Hu, Q.X. Chen, Y. Cui, H.J. Gao, L. Xu, X.Y. Yu, Y. Wang, C.L. Yan, Q. Wang, 4-
Hydroxy cinnamic acid as mushroom preservation: anti-tyrosinase activity kinetics
and application, Int. J. Biol. Macromol. 86 (2016) 489–495.
[27] M. Lin, L.-N. Ke, P. Han, L. Qiu, Q.-X. Chen, H.-T. Lin, Q. Wang, Inhibitory effects of
p-alkylbenzoic acids on the activity of polyphenol oxidase from potato (Solanum
tuberosum), Food Chem. 119 (2010) 660–663.
[28] M. Jimenez-Atienzar, J. Cabanes, F. Gandia-Herrero, F. Garcia-Carmona, Kinetic
analysis of catechin oxidation by polyphenol oxidase at neutral pH, Biochem.
Biophys. Res. Commun. 319 (2004) 902–910.
[29] M.R. Eftink, C.A. Ghiron, Fluorescence quenching studies with proteinS, Anal.
Biochem. 114 (1981) 199–227.
[30] R. Xing, A. Zheng, F. Wang, L. Wang, Y. Yu, A. Jiang, Functionality study of
Na6PMo11FeO40 as a mushroom tyrosinase inhibitor, Food Chem. 175 (2015)
292–299.
[31] Y. Cui, G. Liang, Y.-H. Hu, Y. Shi, Y.-X. Cai, H.-J. Gao, Q.-X. Chen, Q. Wang, Alpha-
substituted derivatives of cinnamaldehyde as tyrosinase inhibitors: inhibitory me-
chanism and molecular analysis, J. Agric. Food Chem. 63 (2015) 716–722.
[32] Y. Jiao, Z. Yang, Y. Jiang, W. Zhai, Study on chemical constituents and antioxidant
activity of anthocyanins from purple sweet potato (Ipomoea batatas L.), Int. J. Food
Eng. 8 (2012).
[33] W.-M. Chai, C.-M. Chen, Y.-S. Gao, H.-L. Feng, Y.-M. Ding, Y. Shi, H.-T. Zhou, Q.-
X. Chen, Structural analysis of proanthocyanidins isolated from fruit stone of chi-
nese hawthorn with potent antityrosinase and antioxidant activity, J. Agric. Food
Chem. 62 (2014) 123–129.
[34] A. Arya, C.Y. Looi, W.F. Wong, M.I. Noordin, S. Nyamathulla, M.R. Mustafa,
M.A. Mohd, In vitro antioxidant, PTP-1B inhibitory effects and in vivo hypogly-
cemic potential of selected medicinal plants, Int. J. Pharmacol. 9 (2013) 50–57.
[35] N. Kanwal, F. Hussain, N. Ahmed, A. Jamil, Antioxidant, thrombolytic and muta-
genic potential of crude protein extracts of seeds and young leaves of Solanum
lycopersicum, Oxidation Commun. 39 (2016) 2291–2300.
[36] W.C. Su, Y.F. Lin, X.P. Yu, Y.X. Wang, X.D. Lin, Q.Z. Su, D.Y. Shen, Q.X. Chen,
Mitochondria-associated apoptosis in human melanoma cells induced by cardanol
monoene from cashew nut shell liquid, J. Agric. Food Chem. 65 (2017) 5620–5631.
[37] G.J. Finn, B.S. Creaven, D.A. Egan, Activation of mitogen activated protein kinase
pathways and melanogenesis by novel nitro-derivatives of 7-hydroxycomarin in
human malignant melanoma cells, Eur. J. Pharm. Sci. 26 (2005) 16–25.
[38] L.D. Azeredo, M.A.A. Azeredo, S.R. de Souza, V.M.L. Dutra, Protein contents and
physicochemical properties in honey samples of Apis mellifera of different floral
origins, Food Chem. 80 (2003) 249–254.
[39] H.Y. Huang, X.Y. Wang, X.L. Ding, Q.X. Xu, S.K. Hwang, W. Fang, J. Du, J.Z. Zhang,
Effect and mechanism of tacrolimus on melanogenesis on A375 human melanoma
cells, Chin. Med. J. 127 (2014) 2966–2971.
[40] R.M. Heriniaina, J. Dong, P.K. Kalavagunta, H.-L. Wu, D.-S. Yan, J. Shang, Effects of
six compounds with different chemical structures on melanogenesis, Chin. J. Nat.
Med. 16 (2018) 766–773.
[41] Y.-J. Zhu, K.-K. Song, Z.-C. Li, Z.-Z. Pan, Y.-J. Guo, J.-J. Zhou, Q. Wang, B. Liu, Q.-
X. Chen, Antityrosinase and antimicrobial activities of trans-cinnamaldehyde
thiosemicarbazone, J. Agric. Food Chem. 57 (2009) 5518–5523.
[42] Y.-F. Lin, Y.-H. Hu, H.-T. Lin, X. Liu, Y.-H. Chen, S. Zhang, Q.-X. Chen, Inhibitory
effects of Propyl Gallate on tyrosinase and its application in controlling pericarp
browning of harvested longan fruits, J. Agric. Food Chem. 61 (2013) 2889–2895.
[43] B.P. Lee, J.L. Dalsin, P.B. Messersmith, Synthesis and gelation of DOPA-Modified
poly(ethylene glycol) hydrogels, Biomacromolecules 3 (2002) 1038–1047.
[44] Y. Zhao, Y. Cao, F.-M. Han, Y. Chen, Study on the interaction between cinnamic
acid and human serum albumin by fluorescence quenching method, Guang Pu Xue
Yu Guang Pu Fen Xi 28 (2008) 904–907.
[45] Y.-L. Lee, S.-Y. Han, P.-Y. Lian, J.-L. Mau, Antioxidant properties of extracts from a
white mutant of the mushroom Hypsizigus marmoreus, J. Food Compos. Anal. 21
(2008) 116–124.
[46] S. Bhagat, M. Arfeen, L. Adane, S. Singh, P.P. Singh, A.K. Chakraborti,
P.V. Bharatam, Guanylthiourea derivatives as potential antimalarial agents:
synthesis, in vivo and molecular modelling studies, Eur. J. Med. Chem. 135 (2017)
339–348.
[47] Q. Aziz, A. Thomas, T. Khambra, A. Tinker, Phenformin has a direct inhibitory
effect on the ATP-sensitive potassium channel, Eur. J. Pharmacol. 634 (2010)
26–32.
[48] X. Berzosa, X. Bellatriu, J. Teixido, J.I. Borrell, An Unusual Michael Addition of 3,3-
dimethoxypropanenitrile to 2-Aryl Acrylates: a convenient route to 4-unsubstituted
5,6-dihydropyrido 2,3-d pyrimidines, J. Org. Chem. 75 (2010) 487–490.
[49] J. Thompson, D. Gillespie, Molecular hybridization with rna probes in con-
centrated-solutions of guanidine thiocyanate, Anal. Biochem. 163 (1987) 281–291.
Y.-X. Wang, et al. Process Biochemistry 85 (2019) 84–96
96
